HomeNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Previous close
$1.50
Day range
$1.40 - $1.65
Year range
$1.11 - $99.75
Market cap
37.81M USD
Avg Volume
664.77K
P/E ratio
0.53
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | -521.00K | -122.56% |
Operating expense | 1.78M | 0.79% |
Net income | -26.60M | -2,094.39% |
Net profit margin | 5.10K | — |
Earnings per share | — | — |
EBITDA | -1.82M | -3.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.96M | 1,750.70% |
Total assets | 9.04M | 163.95% |
Total liabilities | 31.86M | 796.99% |
Total equity | -22.83M | — |
Shares outstanding | 26.63M | — |
Price to book | -1.63 | — |
Return on assets | -72.83% | — |
Return on capital | 46.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.60M | -2,094.39% |
Cash from operations | -2.29M | -170.40% |
Cash from investing | — | — |
Cash from financing | 7.82M | 1,463.20% |
Net change in cash | 5.52M | 1,696.24% |
Free cash flow | -1.47M | -89.55% |
About
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Founded
2000
Headquarters
Website
Employees
3
